IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer

BMC Cancer

Volumn 13, Issue , 2013, Pages 1-9

  Hirakawa, Toshiki ^a   Yashiro, Masakazu ^a   Murata, Akihiro ^a   Hirata, Keiichiro ^a   Kimura, Kenjiro ^a   Amano, Ryosuke ^a   Yamada, Nobuya ^a   Nakata, Bunzo ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

IGF1R; IGFBP3; Pancreatic cancer; Prognosis

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; IGFBP3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PANCREAS CANCER; PREDICTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR INVASION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; VERY ELDERLY; CARCINOMA, PANCREATIC DUCTAL; PANCREATIC NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; RECEPTOR, IGF TYPE 1; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84883259333     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-392     Document Type: Article

References (34)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
2. Cho K, Ishiwata T, Uchida E, Nakazawa N, Korc M, Naito Z, Tajiri T. Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol 2007, 170(6):1964-1974. 10.2353/ajpath.2007.060935, 1899460, 17525264.
3. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004, 198(5):722-731. 10.1016/j.jamcollsurg.2004.01.008, 15110805.
4. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000, 4(6):567-579. 10.1016/S1091-255X(00)80105-5, 11307091.
5. Spannuth WA, Nick AM, Jennings NB, Armaiz-Pena GN, Mangala LS, Danes CG, Lin YG, Merritt WM, Thaker PH, Kamat AA, et al. Functional significance of VEGFR-2 on ovarian cancer cells. Int J Cancer 2009, 124(5):1045-1053. 10.1002/ijc.24028, 2668132, 19058181.
6. Doi Y, Yashiro M, Yamada N, Amano R, Noda S, Hirakawa K. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Ann Surg Oncol 2012, 19(8):2733-2743. 10.1245/s10434-011-2181-6, 22207048.
7. Ozawa F, Friess H, Tempia-Caliera A, Kleeff J, Buchler MW. Growth factors and their receptors in pancreatic cancer. Teratog Carcinog Mutagen 2001, 21(1):27-44. 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9, 11135319.
8. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995, 55(10):2007-2011.
9. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995, 16(2):143-163.
10. Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002, 3(5):298-302. 10.1016/S1470-2045(02)00731-3, 12067807.
11. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004, 4(7):505-518. 10.1038/nrc1387, 15229476.
12. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 2000, 36(10):1224-1228. 10.1016/S0959-8049(00)00102-7, 10882860.
13. Lahm H, Suardet L, Laurent PL, Fischer JR, Ceyhan A, Givel JC, Odartchenko N. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br J Cancer 1992, 65(3):341-346. 10.1038/bjc.1992.69, 1977598, 1558785.
14. Chen SC, Chou CK, Wong FH, Chang CM, Hu CP. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells. Cancer Res 1991, 51(7):1898-1903.
15. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004, 363(9418):1346-1353. 10.1016/S0140-6736(04)16044-3, 15110491.
16. Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007, 28(1):20-47.
17. Butt AJ, Fraley KA, Firth SM, Baxter RC. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology 2002, 143(7):2693-2699. 10.1210/en.143.7.2693, 12072403.
18. Hwa V, Oh Y, Rosenfeld RG. Insulin-like growth factor binding proteins: a proposed superfamily. Acta Paediatr Suppl 1999, 88(428):37-45.
19. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002, 23(6):824-854. 10.1210/er.2001-0033, 12466191.
20. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 2000, 278(6):E967-976.
21. Baxter RC. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 2001, 54(3):145-148. 10.1136/mp.54.3.145, 1187052, 11376125.
22. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, Rosenfeld RG. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996, 28(6):619-637. 10.1016/1357-2725(96)00005-2, 8673727.
23. Sobin LH. TNM, sixth edition: new developments in general concepts and rules. Semin Surg Oncol 2003, 21(1):19-22. 10.1002/ssu.10017, 12923912.
24. Isaji S, Kawarada Y, Uemoto S. Classification of pancreatic cancer: comparison of Japanese and UICC classifications. Pancreas 2004, 28(3):231-234. 10.1097/00006676-200404000-00003, 15084962.
25. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75(1):59-72.
26. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1997, 1332(3):F105-126.
27. Rogers J, Wiltrout L, Nanu L, Fant ME. Developmentally regulated expression of IGF binding protein-3 (IGFBP-3) in human placental fibroblasts: effect of exogenous IGFBP-3 on IGF-1 action. Regul Pept 1996, 61(3):189-195. 10.1016/0167-0115(95)00155-7, 8701035.
28. Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 1993, 268(20):14964-14971.
29. Samaras SE, Hammond JM. Insulin-like growth factor binding protein-3 inhibits porcine granulosa cell function in vitro. Am J Physiol 1995, 268(6 Pt 1):E1057-1064.
30. Chevalier X, Tyler JA. Production of binding proteins and role of the insulin-like growth factor I binding protein 3 in human articular cartilage explants. Brit J Rheumatol 1996, 35(6):515-522.
31. Conover CA, Clarkson JT, Bale LK. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action. Endocrinology 1996, 137(6):2286-2292. 10.1210/en.137.6.2286, 8641177.
32. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT, Fontana JA. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 1994, 158(1):69-78. 10.1002/jcp.1041580110, 7505280.
33. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75(1):73-82.
34. Mauro L, Salerno M, Morelli C, Boterberg T, Bracke ME, Surmacz E. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression. J Cell Physiol 2003, 194(2):108-116. 10.1002/jcp.10207, 12494449.